A £55m investment has been announced for a new institute to help drive innovation and productivity in precision medicine in Northern Ireland via the Future Medicines Institute hosted at QUB.

Our group will be contributing to this project by leading the proteomics platform.

Further coverage of this via a BBC article and an announcement from QUB.

==============================================================================================

The FMI is dedicated to enhancing R&D productivity through interdisciplinary collaboration, integrating expertise from various fields including biomedical science, chemical biology, and data analytics. We strive to address the most pressing health challenges of our time, focusing on precision medicine, novel therapeutics, innovative diagnostics, and advanced healthcare technologies.

  • Drug Discovery and Development: Exploring new compounds and therapies to tackle diseases more effectively.

  • Genomics and Precision Medicine: Harnessing the power of genetics to tailor treatments to individual patients.

  • Diagnostics and Biomarkers: Developing advanced diagnostic methods to identify diseases early and accurately.

==============================================================================================